ID: ALA459541

Max Phase: Preclinical

Molecular Formula: C27H35N5O3

Molecular Weight: 477.61

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN[C@@H](C)C(=O)N[C@H]1CNCC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O

Standard InChI:  InChI=1S/C27H35N5O3/c1-18(28-2)25(33)30-22-17-29-16-15-21-13-14-23(32(21)27(22)35)26(34)31-24(19-9-5-3-6-10-19)20-11-7-4-8-12-20/h3-12,18,21-24,28-29H,13-17H2,1-2H3,(H,30,33)(H,31,34)/t18-,21+,22-,23-/m0/s1

Standard InChI Key:  KMHMGJITTBRABL-AWDZXFJFSA-N

Associated Targets(Human)

BIRC2 Tchem Baculoviral IAP repeat-containing protein 2 (984 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BIRC8 Tchem Baculoviral IAP repeat-containing protein 8 (6 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
XIAP Tchem Inhibitor of apoptosis protein 3 (3673 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 477.61Molecular Weight (Monoisotopic): 477.2740AlogP: 1.34#Rotatable Bonds: 7
Polar Surface Area: 102.57Molecular Species: BASEHBA: 5HBD: 4
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.19CX Basic pKa: 8.60CX LogP: 1.21CX LogD: -0.71
Aromatic Rings: 2Heavy Atoms: 35QED Weighted: 0.48Np Likeness Score: -0.48

References

1. Peng Y, Sun H, Nikolovska-Coleska Z, Qiu S, Yang CY, Lu J, Cai Q, Yi H, Kang S, Yang D, Wang S..  (2008)  Potent, orally bioavailable diazabicyclic small-molecule mimetics of second mitochondria-derived activator of caspases.,  51  (24): [PMID:19049347] [10.1021/jm801254r]
2. Peng Y, Sun H, Lu J, Liu L, Cai Q, Shen R, Yang CY, Yi H, Wang S..  (2012)  Bivalent Smac mimetics with a diazabicyclic core as highly potent antagonists of XIAP and cIAP1/2 and novel anticancer agents.,  55  (1): [PMID:22148838] [10.1021/jm201072x]

Source